UK-based gynaecological health startup Daye, which is known for having invented the CBD tampon that is now used by over 60,000 women in the UK, has completed a £10 million funding round. The company’s successful Series A funding round includes investment from London-based Hambro Perks, an international investment firm which focuses on breakthrough and growth technology companies and included angel funding from investors including Dr Michelle Tempest, Dr Fiona Pathiraja and Martin Varsavsky, founder of Prelude, the largest chain of fertility clinics in the world.

Award winning, early stage Healthtech company, BlueSkeye AI Ltd, has secured £3.4m in funding to pursue its mission to improve people’s quality of life through the use of its proprietary face and voice analysis technology. The round was led by XTX Ventures, which invested alongside Foresight Group (through The Midlands Engine Investment Fund), Praetura Ventures (through Praetura’s GMC Life Sciences Fund), the University of Nottingham and a consortium of high-net-worth individuals.

Oxford Medical Simulation (OMS), a provider of highly realistic virtual reality healthcare training, has raised a further £2.1 million in a funding round that included ACF Investors and angel investor Dr Nicolaus Henke, former chairman of Quantum Black and former head of McKinsey’s global healthcare practice.

A Nottingham company which has devised a blood test that could revolutionise management of tuberculosis (TB) has raised a further £2.4m to further develop the test and support clinical trials.

Enhanc3D Genomics, a functional genomics company unlocking the full potential of the human 3D genome to transform therapeutic development, has raised £10 million in Series A financing to accelerate the development of its proprietary technology platform – GenLink3D [TM]. The financing was led by BGF and Parkwalk Advisors, with support from existing private investors and Bioqube Ventures.

Acurable, an award-winning wearable medical devices company, has announced an €11m investment as a result of its Series A funding round. The funds will be used to accelerate the international expansion of its first product AcuPebble SA100 and drive the company towards its ambition to become the preferred solution for home sleep testing worldwide. The investment was led by Kibo Ventures, along with Mundi Ventures, Kindred Capital, angel investors and Comprador Holdings among others.

Signum Surgical, the medical technology company developing innovative solutions to treat colorectal diseases, announces it has successfully raised a further €2.9 million to support its ongoing regulatory and clinical programs. The financing round was led by Halo Business Angel Network’s MedTech Syndicate, a joint initiative by Enterprise Ireland, InterTrade Ireland and Invest Northern Ireland. Additional investment was secured from the Western Development Commission and other angel investors in the medical device industry.

AMPLY Discovery Limited has raised £900,000 in a mix of equity and grant funding to develop new drug products using its proprietary AI-driven drug discovery platform.  Investors include Co-fund NI, the QUBIS Innovation Fund, the Helix Way Partnership, and Halo Business Angel Network (HBAN).

The Belfast-based biotech company, which is a spin-out from the Queen’s University Belfast, was established in 2021 to commercialise an innovative drug discovery platform which was developed by researchers in the School of Biological Science at Queen’s. Its technology platform has been the subject of more than eight years of scientific research.

Radiology technology start-up Hexarad has completed its Series A funding round with an additional raise of £2.2 million. This is in addition to £2.3 million Hexarad raised in 2021, bringing the full raise to £4.5 million. The round was led by Foresight Group, the leading private equity and infrastructure investment manager, who also invested in 2021, with additional participation from angel investors including healthcare leaders Sachin Agrawal based in the US and Henry Carleton based in the UK.

Thalamos, a platform digitising the Mental Health Act has raised a $1million (£900k) Seed Round, backed by Ascension's Conduit Impact EIS Fund, Angels including Syndicate Room, and a private Seedrs crowdfund. 

VascVersa, an award winning, early-stage regenerative medicine spin out from Queen’s University in Belfast, has completed its second seed funding round, raising over £500,000.  The investment was participated in by Co-Fund NI (managed by Clarendon Fund Managers), QUBIS, the commercialisation arm of Queen’s University Belfast, the Innovation Investment Fund and angel investors from the Halo & Business Angel Network (HBAN).

PhysioMedics is poised to scale its commercial operations after securing growth capital from investors led by Archangels, the world’s longest continually operated business angel syndicate. The investment follows the appointment last year of experienced CEO, Charles Sweeney, to lead the company through the next stage of its growth.